PNC FINANCIAL SERVICES GROUP, INC. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 129 filers reported holding HERON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$410
+26.5%
1170.0%0.00%
Q1 2024$324
-88.2%
117
-92.8%
0.00%
Q4 2023$2,749
+56.3%
1,617
-5.3%
0.00%
Q3 2023$1,759
-11.3%
1,7080.0%0.00%
Q2 2023$1,982
-23.1%
1,7080.0%0.00%
Q1 2023$2,579
-39.6%
1,7080.0%0.00%
Q4 2022$4,270
-46.6%
1,708
-19.0%
0.00%
Q3 2022$8,000
+60.0%
2,1080.0%0.00%
Q2 2022$5,000
-66.7%
2,108
-12.2%
0.00%
Q1 2022$15,000
-6.2%
2,401
+40.6%
0.00%
Q4 2021$16,000
-11.1%
1,7080.0%0.00%
Q3 2021$18,000
-76.9%
1,708
-65.8%
0.00%
Q2 2021$78,000
+25.8%
5,000
+31.2%
0.00%
Q1 2021$62,000
-21.5%
3,811
+2.4%
0.00%
Q4 2020$79,000
+21.5%
3,720
-15.6%
0.00%
Q3 2020$65,000
+6.6%
4,409
+6.6%
0.00%
Q2 2020$61,000
+90.6%
4,136
+53.3%
0.00%
Q1 2020$32,000
+128.6%
2,698
+325.6%
0.00%
Q4 2019$14,000
-6.7%
634
-23.2%
0.00%
Q3 2019$15,000
+25.0%
826
+28.7%
0.00%
Q2 2019$12,000
-99.3%
642
-99.1%
0.00%
-100.0%
Q1 2019$1,802,000
+48.2%
73,748
+57.3%
0.00%
+100.0%
Q4 2018$1,216,000
-22.0%
46,881
-4.7%
0.00%0.0%
Q3 2018$1,558,000
-17.8%
49,212
+0.9%
0.00%
-50.0%
Q2 2018$1,895,000
+7795.8%
48,793
+3152.9%
0.00%
Q3 2017$24,000
+14.3%
1,5000.0%0.00%
Q2 2017$21,000
-8.7%
1,5000.0%0.00%
Q1 2017$23,000
+15.0%
1,5000.0%0.00%
Q4 2016$20,000
+53.8%
1,500
+93.1%
0.00%
Q3 2016$13,000
-7.1%
7770.0%0.00%
Q2 2016$14,000
-73.6%
777
-72.0%
0.00%
Q1 2016$53,000
-50.0%
2,777
-30.2%
0.00%
Q4 2015$106,000
+107.8%
3,977
+93.3%
0.00%
Q3 2015$51,000
-17.7%
2,057
+4.0%
0.00%
Q2 2015$62,0001,9770.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
TANG KEVIN 37,999$706,00024.13%
TANG CAPITAL MANAGEMENT LLC 5,744,096$106,783,00014.43%
BRIDGER MANAGEMENT, LLC 2,846,555$52,917,0004.15%
First Light Asset Management, LLC 1,098,723$20,425,0002.84%
Broadfin Capital, LLC 657,998$12,232,0002.66%
HIGHLAND CAPITAL MANAGEMENT LP 1,606,942$29,873,0001.75%
EMORY UNIVERSITY 129,020$2,398,0001.69%
Mesirow Financial Investment Management, Inc. 24,112$430,0001.57%
Congress Park Capital LLC 109,665$1,945,0001.54%
KINGDON CAPITAL MANAGEMENT, L.L.C. 830,821$15,445,0001.52%
View complete list of HERON THERAPEUTICS INC shareholders